Lilly spends $6.3 billion to acquire Centessa and accelerate its move into the sleep-disorder treatment market. 🧬 Eli Lilly has announced a deal to acquire Centessa for $38 per share in cash, with additional contingent payments tied to FDA milestones, bringing the total

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin